Iraqi Journal of Hematology

Scope & Guideline

Your Gateway to Hematology Excellence

Introduction

Explore the comprehensive scope of Iraqi Journal of Hematology through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Iraqi Journal of Hematology in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2072-8069
PublisherWOLTERS KLUWER MEDKNOW PUBLICATIONS
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationIRAQI J HEMATOL / Iraqi J. Hematol.
Frequency2 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressWOLTERS KLUWER INDIA PVT LTD, A-202, 2ND FLR, QUBE, C T S NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra 400059, INDIA

Aims and Scopes

The Iraqi Journal of Hematology serves as a pivotal platform for disseminating research and advancements in hematology, with a strong emphasis on clinical studies and diagnostic innovations. The journal focuses on a variety of hematological conditions, treatments, and the implications of emerging research in the field.
  1. Clinical Research in Hematology:
    The journal publishes clinical studies that assess treatment outcomes, diagnostic techniques, and patient management strategies for various hematological disorders, such as leukemia, thalassemia, and lymphoma.
  2. Diagnostic Innovations:
    There is a consistent focus on the evaluation and comparison of diagnostic methods, including novel techniques for blood tests and cross-matching, which contribute to improved patient outcomes.
  3. Epidemiological Studies:
    The journal frequently includes epidemiological research that examines the prevalence and risk factors associated with hematological diseases within specific populations, particularly in Iraq.
  4. Therapeutic Interventions:
    Research on the efficacy and safety of treatment regimens, including chemotherapy, stem cell transplantation, and novel therapies, is a core area of the journal's focus.
  5. Patient-Centered Outcomes:
    Studies that explore quality of life, patient experiences, and the psychosocial aspects of living with hematological conditions are also highlighted, reflecting a comprehensive approach to patient care.
Recent publications in the Iraqi Journal of Hematology indicate a dynamic evolution of research themes, with several emerging scopes gaining traction. These trends are reflective of both global advancements and localized health concerns.
  1. Impact of COVID-19 on Hematological Patients:
    There is an increasing focus on how COVID-19 affects patients with existing hematological conditions, including complications and treatment outcomes, which is crucial given the pandemic's widespread impact.
  2. Personalized Medicine and Genetic Studies:
    Emerging research on the genetic factors influencing treatment responses in hematological diseases underscores a growing interest in personalized medicine, aiming to tailor treatments based on individual genetic profiles.
  3. Nutritional and Environmental Factors:
    Recent studies evaluating the role of nutritional deficiencies, such as Vitamin D levels in thalassemia patients, highlight a trend towards understanding how environmental and lifestyle factors affect hematological health.
  4. Innovative Therapeutics and Treatment Regimens:
    There is a marked increase in studies assessing novel therapies and regimens for hematological diseases, reflecting ongoing advancements in treatment methodologies and patient management.
  5. Quality of Life and Patient Experience Research:
    An emerging theme is the assessment of quality of life and psychosocial factors among patients with hematological disorders, emphasizing the importance of holistic patient care.

Declining or Waning

While the Iraqi Journal of Hematology continues to thrive in several areas, certain themes are becoming less prominent over time, reflecting shifts in research focus and clinical priorities.
  1. Basic Science Research:
    There is a noticeable decrease in the number of publications focusing on the fundamental biological and molecular mechanisms underlying hematological diseases, suggesting a shift towards more clinically relevant studies.
  2. Rare Hematological Disorders:
    Research on rare hematological conditions appears to be declining, possibly due to a reduced number of cases and the challenges associated with studying these less common disorders.
  3. Historical and Longitudinal Studies:
    The journal has seen fewer studies that focus on historical perspectives or long-term outcomes of hematological treatments, indicating a preference for current and immediate clinical applications.

Similar Journals

Egyptian Journal of Haematology

Advancing Hematology: Insights from Egypt and Beyond
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1110-1067Frequency: 4 issues/year

The Egyptian Journal of Haematology, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, stands as a pivotal resource in the field of hematology, particularly within the context of Egypt and the broader Middle Eastern region. This journal is dedicated to disseminating high-quality research that explores the latest advancements in blood disorders, hematologic malignancies, and transfusion medicine. With a focus on original research, case studies, and reviews, it aims to provide a comprehensive platform for hematologists, researchers, and healthcare professionals to enhance their understanding and management of hematological conditions. Although it is not an open-access journal, the rigorous peer-review process ensures that only the most impactful studies are published, contributing to the journal's reputation in the academic community. The Egyptian Journal of Haematology serves as an essential tool for advancing knowledge, improving clinical outcomes, and fostering collaboration among experts in the field.

ACTA HAEMATOLOGICA

Pioneering Insights into Hematological Practices
Publisher: KARGERISSN: 0001-5792Frequency: 6 issues/year

ACTA HAEMATOLOGICA, published by KARGER, is a prestigious journal established in 1948, dedicated to the field of hematology and related medical sciences. With an ISSN of 0001-5792 and an E-ISSN of 1421-9662, this journal stands out with a Q2 ranking in both Hematology and Miscellaneous Medicine categories as of 2023. Researchers and professionals can benefit from its high-quality peer-reviewed articles, contributing to a more profound understanding and advancement of hematological practices. Although it does not offer open access options, ACTA HAEMATOLOGICA remains an essential resource for researchers in Switzerland and worldwide, providing critical insights and fostering discourse among academic and clinical communities. The journal's address is located in the heart of Basel, Switzerland, ensuring its robust connection to European medical research networks. With a firm commitment to excellence, this publication plays a vital role in disseminating knowledge, guiding future innovations in the field.

Journal of Blood Medicine

Empowering Research: Your Gateway to Innovations in Hematology
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-2736Frequency: 1 issue/year

The Journal of Blood Medicine, published by DOVE MEDICAL PRESS LTD, stands as a vital resource in the field of hematology, focusing on the latest research developments and clinical advancements in blood medicine. With an impact factor reflective of its growing relevance, this open-access journal has been delivering quality scholarly work since 2010, ensuring that critical research is readily available to the global scientific community. The journal operates under an open-access model, further enhancing its dissemination and accessibility to researchers, professionals, and students alike. In the 2023 rankings, it secured a Q3 category status within hematology and achieved a commendable 76th rank out of 137 in Scopus listings, indicating its commitment to quality and innovation in this specialized area. Located in New Zealand, the journal's diverse topics encompass clinical research, treatment modalities, and emerging therapies, contributing significant insights vital for shaping future advancements in blood medicine.

HemaSphere

Connecting researchers, clinicians, and students in hematology.
Publisher: WILEYISSN: Frequency: 12 issues/year

HemaSphere, published by WILEY, stands at the forefront of hematology research, offering a vital platform for the dissemination of cutting-edge findings in the field. Since its inception in 2017 and official transition to Open Access in 2018, the journal has positioned itself as a leading conduit for high-impact research, maintaining a prestigious Q1 quartile ranking in the Hematology category as of 2023. Addressed in the United States at 111 River St, Hoboken, NJ, HemaSphere aims to foster a global dialogue among researchers, clinicians, and students by providing unrestricted access to high-quality content that encompasses clinical and experimental advancements. With an array of engaging articles, reviews, and commentaries, HemaSphere contributes significantly to the advancement of hematology, ensuring that critical knowledge is readily accessible to enhance patient care and innovative research. To explore the latest developments and breakthroughs in this dynamic field, we invite scholars, professionals, and students to engage with HemaSphere and elevate their understanding of hematologic science.

Journal of Hematology

Bridging Knowledge Gaps in Hematology
Publisher: ELMER PRESS INCISSN: 1927-1212Frequency: 4 issues/year

The Journal of Hematology, published by ELMER PRESS INC, serves as a pivotal platform for disseminating cutting-edge research in the field of hematology. With an ISSN of 1927-1212 and an E-ISSN of 1927-1220, this journal is committed to advancing scientific knowledge and clinical practice through high-quality peer-reviewed articles encompassing all aspects of blood disorders, from basic science to health policy implications. While the journal currently operates under a traditional access model, it nonetheless prioritizes the rapid publication of significant findings, ensuring that researchers, clinicians, and students have timely access to the latest advancements in hematological research. Positioned to bridge gaps in knowledge and foster collaboration among scholars worldwide, the Journal of Hematology is an essential resource for anyone invested in this vital area of medicine.

CURRENT OPINION IN HEMATOLOGY

Connecting groundbreaking research to clinical practice.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1065-6251Frequency: 6 issues/year

CURRENT OPINION IN HEMATOLOGY is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the latest advancements and insights in the field of hematology. With an impressive impact factor and ranked in the first quartile (Q1) of its category, this journal serves as a vital resource for researchers, clinicians, and students seeking to stay informed on contemporary issues and emerging trends in hematological research and treatment. Established in 1994, it showcases critical reviews, expert commentary, and systematic analyses across a broad spectrum of hematology topics, contributing significantly to clinical and experimental knowledge through its robust editorial standards. While offering traditional subscription access, CURRENT OPINION IN HEMATOLOGY remains committed to providing a platform that bridges the gap between fundamental research and clinical application, making it indispensable for professionals dedicated to advancing patient care and scientific understanding in hematology.

AMERICAN JOURNAL OF HEMATOLOGY

Empowering Discoveries in Blood Disorders
Publisher: WILEYISSN: 0361-8609Frequency: 12 issues/year

American Journal of Hematology, published by Wiley, stands as a premier outlet for the dissemination of cutting-edge research in the field of hematology. With a commendable impact factor and ranked #9 out of 137 in the Scopus medicine category, this journal has established a robust presence since its inception in 1976. Operating in the Q1 quartile for hematology, it serves as a crucial resource for researchers, clinicians, and students dedicated to understanding blood disorders and advancing treatment methodologies. While the journal does not currently offer open access options, it remains highly regarded for its rigorous peer-review process and impactful contributions to the scientific community. With coverage extending into 2024, the American Journal of Hematology is committed to fostering innovation and collaboration within the hematological sciences.

Turkish Journal of Hematology

Innovating knowledge in the field of hematology since 1999.
Publisher: GALENOS PUBL HOUSEISSN: 1300-7777Frequency: 4 issues/year

Turkish Journal of Hematology is an esteemed publication dedicated to advancing the field of hematology, producing influential research since its inception in 1999 under the auspices of GALENOS PUBL HOUSE. With an Open Access model, it facilitates widespread dissemination of knowledge, allowing researchers, clinicians, and students to stay abreast of the latest developments in blood disorders and treatments. With an ISSN of 1300-7777 and an E-ISSN of 1308-5263, the journal holds a commendable position in the academic community, evidenced by its 2023 Q3 ranking within the hematology category and its standing at #80 out of 137 in the Scopus database, placing it in the 41st percentile. Covering a wide scope of topics within hematology, this journal serves as a critical resource for disseminating innovative research and clinical practices pertinent to the ongoing challenges faced in this vital area of medicine. With its continuous publication until 2024, Turkish Journal of Hematology remains a beacon for enhancing the understanding and treatment of hematological conditions within the Turkish and global medical communities.

Hematology Reports

Empowering researchers to transform hematology.
Publisher: MDPIISSN: 2038-8322Frequency: 4 issues/year

Hematology Reports is an esteemed academic journal in the field of hematology, dedicated to advancing the understanding of blood disorders and their treatment. Published by MDPI, a leading Swiss publisher known for its commitment to open access since 2009, this journal provides a valuable platform for researchers and healthcare professionals to disseminate innovative findings and foster collaboration within the academic community. The journal features an array of articles ranging from clinical studies to laboratory research, and is indexed in Scopus, where it currently holds a rank of 113 out of 137 in the Medicine - Hematology category, placing it in the 17th percentile. As an open-access journal, Hematology Reports ensures that critical research is accessible to a global audience, supporting the dissemination of knowledge that has the potential to improve patient outcomes. This journal is an essential resource for those engaged in the study and treatment of hematological conditions, encouraging dialogue and the exchange of ideas to enhance clinical practices.

Therapeutic Advances in Hematology

Advancing hematology through innovative research.
Publisher: SAGE PUBLICATIONS LTDISSN: 2040-6207Frequency: 1 issue/year

Therapeutic Advances in Hematology is a prestigious, peer-reviewed journal dedicated to advancing the field of hematology through innovative research and clinical studies. Published by SAGE Publications Ltd, this journal has become a vital resource for hematology professionals and researchers since its inception in 2010. With its impactful Q1 ranking in Hematology and a Scopus rank of 62 out of 137, it firmly establishes itself as a leader in disseminating significant findings and therapeutic approaches. The journal has been committed to open access since 2019, ensuring that its cutting-edge research is readily available to the global scientific community. Covering a broad scope of topics within hematology, Therapeutic Advances in Hematology is an essential platform for those seeking to enhance their understanding and implementation of therapeutic practices in hematological conditions. The journal embraces submissions from both clinical and laboratory perspectives, fostering collaboration and dialogue among researchers, clinicians, and students alike.